In vitro antifungal activities of luliconazole, a new topical imidazole

References

• Koga H, Tsuji Y, Inoue K, et al. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J Infect Chemother 2006; 12: 163–165
   PubMedGoogle Scholar
• Uchida K, Nishiyama Y, Yamaguchi H. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent. J Infect Chemother 2004; 10: 216–219
   PubMedGoogle Scholar
• Niwano Y, Kuzuhara N, Kodama H, et al. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Antimicrob Agents and Chemother 1998; 42: 967–970
   PubMed Web of Science ®Google Scholar
• Watanabe S, Takahashi H, Nishikawa T, et al. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis – comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomized double-blind study. Mycoses 2007; 50: 35–40
   PubMed Web of Science ®Google Scholar
• Watanabe S, Takahashi H, Nishikawa T, et al. A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 2 weeks of bifonazole 1% cream treatment for tinea pedis. Mycoses 2006; 49: 236–241
   PubMed Web of Science ®Google Scholar
• Uchida K, Yamaguchi H. Status and issues of preclinical evaluation of the therapeutic effects of newly developed antifungal agents. Jpn J Med Mycol 2004; 45: 83–91
   Google Scholar
• Brennan B, Leyden J. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J Am Acad Dermatol 1997; 36: s3–s8
   Web of Science ®Google Scholar
• Rex JH, Pfller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing: Clin Microbiol Rev 1993; 6: 367–381
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute/National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
   Google Scholar
• Standardization Committee of Japanese Society of Medical Mycology. Report of the Standardization Committee of Japanese Society of Medical Mycology 1995–1997. Jpn J Med Mycol 1999; 40: 239–257.
   Google Scholar
• Clinical Laboratory Standards Institute/National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997
   Google Scholar
• Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol 2000; 38: 337–341
   PubMedGoogle Scholar
• Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15: 21–57
   PubMed Web of Science ®Google Scholar
• Midgley G. The lipophilic yeasts: state of the art and prospects. Med Mycol 2000; 38(Suppl. I)9–16
   Google Scholar
• Sei Y, Hamguti T, Ninomiya J, Nakabayasgi A, Takiuchi I. Seborrhoeic dermatitis: treatment with anti-mycotic agents. J Dermatol 1994; 21: 334–340
   Google Scholar
• Segal R, David M, Ingber A, Lurie R, Sandbank M. Treatment with bifonazole shampoo for seborrhoeic dermatitis: a randomized, double-blind study. Acta Derm Venereol 1992; 72: 454–455
   PubMedGoogle Scholar
• Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695–700
   PubMed Web of Science ®Google Scholar
• Skinner RB, Noah PW, Taylor RM, et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 12: 852–856
   PubMed Web of Science ®Google Scholar
• Katsambas A, Antoniou C, Frangouli E, et al. A double-blind trial of treatment of seborrheic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol 1989; 121: 353–357
   PubMed Web of Science ®Google Scholar
• Hammer KA, Carson CF, Riley TV. In vitro activities of ketoconazole, econazole, miconazole and Melaleuca alternifolia (tea tree) oil against Malassezia species. Antimicrob Agents Chemother 2000; 44: 467–469
   PubMed Web of Science ®Google Scholar
• Gueho E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996; 69: 337–355
   PubMed Web of Science ®Google Scholar
• Hirai A, Kano R, Makimura K, et al. Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int J Syst Evol Microbiol 2004; 54: 623–627
   PubMed Web of Science ®Google Scholar
• Sugita T, Takashima M, Shinoda H, et al. New yeast species, Malassezia dermatis isolated from patient with atopic dermatitis. J Clin Microbiol 2002; 40: 1363–1367
   PubMed Web of Science ®Google Scholar
• Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: Comparison with other diseases and healthy subjects. J Invest Dermatol 2008; 128: 345–351
   PubMed Web of Science ®Google Scholar
• Sugita T, Tajima M, Ito T, et al. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005; 43: 2824–2829
   PubMed Web of Science ®Google Scholar
• Makimura K, Tamura Y, Mochizuki T, et al. Phylogenetic classification and species identification of dermatophytes strains based on DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Clin Microbiol 1999; 37: 920–924
   PubMed Web of Science ®Google Scholar
• Makimura K, Tamura Y, Kudo M, et al. Species identification and strain typing of Malassezia species stock strains and clinical isolates based on the DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. J Med Microbiol 2000; 49: 29–35
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Buschelman B, Bale MJ, et al. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. Microbiol Infect Dis 1994; 19: 9–13
   PubMedGoogle Scholar
• Uchida K, Nishiyama Y, Tanaka T, Yamaguchi H. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species. Int J Antimicrobial Agents 2003; 21: 234–238
   PubMed Web of Science ®Google Scholar
• Committee for Epidemiology, The Japanese Society for Medical Mycology. An epidemiological survey of dermatomycoses in Japan, 2002. Jpn J Med Mycol 2006; 47: 103–111.
   Google Scholar
• Odom RB. Updated on topical therapy for superficial fungal infections: focus on butenafine. J Am Acad Dermatol 1997; 36: S1–2
   PubMed Web of Science ®Google Scholar
• Chan YC, Friedlander SF. New treatments for tinea captis. Curr Opin Infect Dis 2004; 17: 97–103
   Google Scholar
• Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol 2002; 47: 286–290
   PubMed Web of Science ®Google Scholar
• Gupta AK, Summerbell RC. Tinea capitis. Med Mycol 2000; 38: 255–287
   PubMed Web of Science ®Google Scholar
• Aly R, Hay RJ, Del Palacio A, Galimbertis R. Epidemiology of tinea captis. Med Mycol 2000; 38: 183–188
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Kawasaki M, Tanabe H, et al. Molecular epidemiology of Trichophyton tonsurans isolated in Japan using RFLP analysis of non-transcribed spacer regions of ribosomal RNA genes. Jpn J Infect Dis 2007; 60: 188–192
   Google Scholar
• Kasai T. Epidemiological survey of Trichophyton tonsurans infection in Tohoku district and its clinical problems. Jpn J Med Mycol 2005; 46: 87–91
   Google Scholar
• Gupta AK, Einarson TR, Summerbell RC, Shear NH. An over view of topical antifungal therapy in dermatomycoses. Drugs 1998; 55: 645–674
   PubMed Web of Science ®Google Scholar
• Niwano Y, Ohmi T, Seo A, et al. Lanoconazole and its related optically active compound NND-502: novel antifungal imidazoles with a ketene dithioacetal structure. Curr Med Chem-Anti-Infective Agents 2003; 2: 147–160
   Google Scholar
• Nakamura H. Isoprothiolane, a new systemic pesticide for the control of rice blast and plant hoppers. Rev Plant Prot Res 1977; 10: 1–5
   Google Scholar
• Takase S, Takada A, Yasuhara M, Sato H, Matsuda Y. Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis. Gastroenterol Jpn 1988; 23: 639–645
   PubMedGoogle Scholar
• Oka A, Yamasaki T, Shibatani M, Suzuki T, Saito T. Efficacy of isoprothiolane for the treatment of fat necrosis in cattle. Br Vet J 1988; 144: 507–514
   Google Scholar
• Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J Invest Dermatol Symp Proc 2005; 10: 194–197
   Google Scholar